Skip to main content
Mabion S.A. logo

Mabion S.A. — Investor Relations & Filings

Ticker · MAB ISIN · PLMBION00016 LEI · 259400KG5JVQPPZL6X53 WAR Manufacturing
Open in API
Filings indexed 1,002 across all filing types
Latest filing 2025-05-12 AGM Information
Country PL Poland
Listing WAR MAB

About Mabion S.A.

https://www.mabion.eu/en/

Mabion S.A. is an integrated Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for the development and manufacturing of protein-based biotherapeutics. The company specializes in monoclonal antibodies and biosimilars, offering a complete workflow from cell line development and banking to process optimization and large-scale GMP manufacturing. Core competencies include upstream processing using mammalian cell cultures, downstream purification involving chromatography and viral clearance, and technology transfer for scale-up. Mabion partners with pharmaceutical and biotechnology companies to support both clinical and commercial supply, streamlining the path from gene to final drug product.

Recent filings

Filing Released Lang Actions
Zgłoszenie przez akcjonariusza projektu uchwały do sprawy objętej porządkiem obrad Zwyczajnego Walnego Zgromadzenia Spółki zwołanego na dzień 26 maja 2025 r. - Content (PL)
AGM Information Classification · 94% confidence The document text is a 'raport bieżący' (current report) from Mabion S.A. It explicitly references a previous announcement about convening an Annual General Meeting (ZWZ) and details a shareholder (Twiti Investments Limited) submitting a draft resolution concerning the amendment of the Company's Statute and authorizing the Management Board to increase share capital within the authorized capital framework, including the possibility of excluding pre-emptive rights. This action—a shareholder proposing a resolution related to capital structure changes ahead of a general meeting—is a specific corporate governance event. Since the document is an announcement *about* a proposed resolution for the AGM, and it involves capital structure changes (though proposed by a shareholder), it relates closely to the AGM process and shareholder actions. However, the core subject is the proposal for a significant change to the capital structure (Statute amendment for authorized capital increase). Given the options, this is a notification regarding a significant corporate action proposed for a shareholder meeting. It is not a full AGM presentation (AGM-R), nor is it a general capital financing update (CAP) which usually implies the company executing the financing. It is a specific announcement related to the proceedings of the upcoming general meeting concerning capital structure. Since the content is about a shareholder proposing a resolution that directly impacts the company's capital structure and governance rules (Statute change), and it is being announced via a current report, it fits best as a specific corporate governance/shareholder action announcement. Given the options, and the focus on the proposed resolution for the ZWZ, it is most closely related to the general meeting context, but the content itself is a notification of a proposed change to the capital structure/statute. Since it is a formal notification of a specific event/proposal related to the AGM agenda, and not the final voting results (DVA) or the AGM presentation itself (AGM-R), and it deals with capital structure changes, it could potentially be CAP or RNS. However, the context is clearly tied to the ZWZ agenda. Since the document is short and is announcing the submission of a resolution for the ZWZ, and the resolution concerns capital structure, I will classify it as a Regulatory Filing (RNS) as it is a specific, non-standard announcement that doesn't perfectly fit the other specific categories like DIV, DIRS, or ER, but is a required disclosure related to the AGM. Alternatively, because the resolution directly concerns capital structure, CAP is plausible, but RNS is safer for specific procedural announcements. Given the nature of Polish regulatory filings (where this appears to originate), these specific shareholder proposal announcements often fall under general regulatory disclosures (RNS) unless they are explicitly about voting results (DVA) or the meeting materials themselves (AGM-R). I will lean towards RNS as the most appropriate fallback for a specific procedural announcement not covered elsewhere.
2025-05-12 Polish
Wniosek o rozszerzenie porządku obrad Zwyczajnego Walnego Zgromadzenia Mabion S.A
AGM Information Classification · 98% confidence The document is a formal letter dated May 5, 2025, from Polfarmex S.A. to Mabion S.A. The sender, a shareholder holding 9.12% of Mabion S.A., is formally requesting the inclusion of a new agenda item concerning the amendment of a previous resolution regarding a 'Program Motywacyjny' (Incentive Program) for the upcoming Extraordinary General Meeting (Walne Zgromadzenie) scheduled for May 26, 2025. The document then lists the proposed full agenda, which includes standard AGM items like approving financial statements for 2024 and granting discharge to management, as well as the requested new item. Crucially, it includes 'ZAŁĄCZNIK nr1' which is the draft resolution itself detailing the proposed changes to the Incentive Program, involving subscription warrants and share capital changes. This entire communication is focused on proposing changes to the agenda and structure of an upcoming shareholder meeting, which strongly aligns with the purpose of soliciting votes or providing information related to such a meeting. While it contains elements related to compensation (Program Motywacyjny) and capital changes, the primary function of the document is to formally request and detail items for a General Meeting. This fits best under Proxy Solicitation & Information Statement (PSI), as it is providing detailed information (the draft resolution) to influence the outcome of the meeting, or AGM-R if it were the final materials, but since it is a request to change the agenda, PSI or AGM-R are the closest. Given the context of proposing changes to the agenda and providing the detailed draft resolution for the upcoming meeting, PSI is highly relevant, but since the core event is the General Meeting itself, AGM-R (AGM Information) is also a strong candidate, especially as it details the proposed resolutions. However, the document is a shareholder's request to *add* an item, which is a precursor to the final AGM materials. Since it details the proposed resolutions for the meeting, and the meeting itself is an AGM, AGM-R is the most appropriate classification for materials directly related to the agenda and resolutions of the Annual General Meeting.
2025-05-06 Polish
Wniosek o rozszerzenie porządku obrad Zwyczajnego Walnego Zgromadzenia Mabion S.A
AGM Information Classification · 98% confidence The document is a formal letter dated May 5, 2025, from Polfarmex S.A. to Mabion S.A. The sender, a shareholder holding 9.12% of Mabion S.A., is formally requesting the inclusion of a new agenda item concerning the amendment of a previous resolution regarding a 'Program Motywacyjny' (Incentive Program) for the upcoming Extraordinary General Meeting (Walne Zgromadzenie) scheduled for May 26, 2025. The document then lists the proposed full agenda, which includes standard AGM items like approving financial statements for 2024 and granting discharge to management, as well as the requested new item. Crucially, it includes 'ZAŁĄCZNIK nr1' which is the draft resolution itself detailing the proposed changes to the Incentive Program, involving subscription warrants and share capital changes. This entire communication is focused on proposing changes to the agenda and structure of an upcoming shareholder meeting, which strongly aligns with the purpose of soliciting votes or providing information related to such a meeting. While it contains elements related to compensation (Program Motywacyjny) and capital changes, the primary function of the document is to formally request and detail items for a General Meeting. This fits best under Proxy Solicitation & Information Statement (PSI), as it is providing detailed information (the draft resolution) to influence the outcome of the meeting, or AGM-R if it were the final materials, but since it is a request to change the agenda, PSI or AGM-R are the closest. Given the context of proposing changes to the agenda and providing the detailed draft resolution for the upcoming meeting, PSI is highly relevant, but since the core event is the General Meeting itself, AGM-R (AGM Information) is also a strong candidate, especially as it details the proposed resolutions. However, the document is a shareholder's request to *add* an item, which is a precursor to the final AGM materials. Since it details the proposed resolutions for the meeting, and the meeting itself is an AGM, AGM-R is the most appropriate classification for materials directly related to the agenda and resolutions of the Annual General Meeting.
2025-05-06 Polish
Otrzymanie wniosku akcjonariusza o rozszerzenie porządku obrad Zwyczajnego Walnego Zgromadzenia o punkt w sprawie zmian w Programie Motywacyjnym - Content (PL)
AGM Information Classification · 98% confidence The document text explicitly discusses the agenda for a 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) scheduled for May 26, 2025. It details the items to be voted upon, including the approval of the 2024 financial statements, remuneration reports, and changes to the company's bylaws and a 'Program Motywacyjny' (Incentive Program). The core subject matter is the preparation and announcement of items for a shareholder meeting, which aligns directly with the scope of an Annual General Meeting (AGM) or related preparatory/procedural announcements. Since the text details the agenda and a shareholder's request to add an item to the agenda of the upcoming AGM, the most appropriate classification is AGM Information (AGM-R). It is not a DEF 14A (Remuneration Information) because it covers the entire meeting agenda, nor is it a DVA (Declaration of Voting Results) as the meeting has not yet occurred.
2025-05-06 Polish
Otrzymanie wniosku akcjonariusza o rozszerzenie porządku obrad Zwyczajnego Walnego Zgromadzenia o punkt w sprawie zmian w Programie Motywacyjnym
AGM Information Classification · 99% confidence The document text explicitly discusses the agenda for a 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) scheduled for May 26, 2025. It details the inclusion of a new item requested by a major shareholder concerning a resolution about the 'Program Motywacyjny' (Incentive Program). The agenda items (1 through 18) cover standard AGM topics like approving financial statements, granting discharge (absolutorium), and amending the company's articles of association. This content is directly related to the proceedings and materials of an Annual General Meeting. Therefore, the classification is AGM-R (AGM Information). The document length (4761 chars) is substantial enough to be the primary material, not just a brief announcement of publication (RPA).
2025-05-06 Polish
Sprawozdanie Zarządu
Audit Report / Information Classification · 95% confidence The document text consists entirely of XML digital signature blocks (DSig and XAdES structures). Within these structures, a reference URI is present: "Sprawozdanie%20Zarz%C4%85du%20z%20dzia%C5%82alno%C5%9Bci%20Mabion%20SA%20za%202024.xhtml". This translates to "Sprawozdanie Zarządu z działalności Mabion SA za 2024", which means "Management Board Report on the activities of Mabion SA for 2024" in Polish. This strongly indicates the document is a formal annual report or a management report covering the previous year (2024). Since the document is the signed content itself (not an announcement about it, and the length is substantial at 36k characters), it is classified as a Management Report (MDA) or potentially an Annual Report (10-K). Given the specific title mentions "Sprawozdanie Zarządu" (Management Board Report), MDA is a more precise fit than the comprehensive 10-K, which usually implies the full SEC filing structure. However, in many contexts, the Management Board Report is a key component of the Annual Report. Since the definition for MDA is "Management's detailed explanation of financial results, business trends, and outlook," and the title explicitly names the Management Board Report, MDA is the best fit among the provided options, assuming this is the core document being signed, rather than the full statutory 10-K. FY 2024
2025-04-24 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.